Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

Introduction: Quick release bromocriptine (BROM-QR), currently approved for glycemic control, reduces the risk of cardiovascular events in adults with type-2 diabetes mellitus (T2DM). This study evaluates the effect of BROM-QR on homocysteine (HOMC) and high sensitive C-reactive protein (hs-CRP), th...

Full description

Bibliographic Details
Main Authors: Mitra Niafar, Leili Pourafkari, Kavus Shahsavarinia, Nushin Milanchian, Farhad Niafar, Nader Nader
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2016-03-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
Homocysteine
bromocriptine
CRP
Online Access:http://journals.tbzmed.ac.ir/JCVTR/Manuscript/JCVTR-8-8.pdf

Internet

http://journals.tbzmed.ac.ir/JCVTR/Manuscript/JCVTR-8-8.pdf

Similar Items